Abstract
An anti-inflammatory 1,2,4-phenylenetriamine-containing series of FMS inhibitors with a potential to form reactive metabolites was transformed into a series with equivalent potency by incorporation of carbon-based replacement groups. Structure-based modeling provided the framework to efficiently effect this transformation and restore potencies to previous levels. This optimization removed a risk factor for potential idiosyncratic drug reactions.
Original language | English (US) |
---|---|
Pages (from-to) | 3632-3637 |
Number of pages | 6 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 18 |
Issue number | 12 |
DOIs | |
State | Published - Jun 15 2008 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry
Keywords
- Anti-inflammatory activity
- CSF-1R
- Colony-stimulating factor-1
- FMS
- Idiosyncratic drug reactions
- M-CSF
- Macrophages
- cFMS